Icahn School of Medicine at Mount Sinai

 

Icahn School of Medicine at Mount Sinai
K

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

By Icahn School of Medicine at Mount Sinai FEATURING Kuo-Kai Chin
By Icahn School of Medicine at Mount Sinai FEATURING Kuo-Kai Chin
21 views
July 2, 2024
Comments 0
Login to view comments. Click here to Login
Myeloid Malignancy Workshop
06:03

Strategies to Overcome Immune Dysregulation in MPNs

Icahn School of Medicine at Mount Sinai

C. Cimen Bozkus

30 views
26:23

Boosting MHC:TCR Interactions in AML

Icahn School of Medicine at Mount Sinai

I. Aifantis

27 views
20:26

Therapeutic Targeting of RNA Splicing Factor Mutant Leukemias

Icahn School of Medicine at Mount Sinai

O. Abdel-Wahab

57 views
03:33

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associ…

Icahn School of Medicine at Mount Sinai

K. Chin

21 views
36:18

Stem Cell Pathways, Aging, and Cancer Evolution in MPN

Icahn School of Medicine at Mount Sinai

C. Jamieson

19 views
28:30

Leveraging Dysregulated Signaling Networks for Therapeutic Benefit i…

Icahn School of Medicine at Mount Sinai

S. Oh

19 views
26:45

Targeting Mutant Calreticulin in MPN

Icahn School of Medicine at Mount Sinai

A. Mullally

45 views
18:59

BMT for MDS: Updates and Tricky Case Discussion

Icahn School of Medicine at Mount Sinai

A. DeZern

170 views
27:08

Emerging Landscape of Treating Anemia in LR-MDS

Icahn School of Medicine at Mount Sinai

R. Komrokji

85 views
29:54

State-of-the-Art Management of Systemic Mastocytosis

Icahn School of Medicine at Mount Sinai

D. DeAngelo

81 views
12:06

MDS: Prospects for Individualized Therapy With Targeted Therapies Po…

Icahn School of Medicine at Mount Sinai

L. Silverman

67 views
48:04

Integrating Targeted Therapies in AML

Icahn School of Medicine at Mount Sinai

H. Kantarjian

411 views
34:57

BPDCN: Current and Future Directions

Icahn School of Medicine at Mount Sinai

N. Pemmaraju

460 views